Osteoporosis

Nonphysician health professionals should discuss adequate nutrition, including daily recommended calcium and vitamin D intake, with patients aged 50 years and older to help prevent and manage fragility fractures, according to new EULAR “points to consider” published in the Annals of the Rheumatic Diseases.

A bigger breakfast paired with a smaller dinner may reduce the risk for death in patients with diabetes, according to a recent study published in Diabetes Care. This was the top story in endocrinology last week.

Leading bone health organizations have issued guidance for health care professionals treating people with osteoporosis during the COVID-19 pandemic, outlining important treatment adjustments for osteoporosis therapies and alternative methods for assessing fracture risk in the absence of a DXA scan.

Implementation of a fracture liaison service program may lead to effective treatment for osteoporosis among patients with fragility fractures of the hip, according to results.

Women aged 65 years or younger who underwent surgery and adjuvant chemotherapy for gynecologic cancer appeared at higher risk for osteopenia and osteoporosis as early as 1 year after treatment, according to study results presented at the virtual Society of Gynecologic Cancer Annual Meeting.

As the COVID-19 pandemic continues to worsen, endocrinologists are confronting changes large and small to the way they practice medicine. For some, that means preparing to abandon the typical clinic day and assist as needed as internists. For others, it means navigating an unprecedented, nationwide shift to telemedicine and virtual communication, all while prioritizing the patients who still urgently need an in-person consultation and the risks that come with it.

According to study results, dual X-ray absorptiometry as a screening tool for local bone loss may be beneficial in postmenopausal women at risk for distal radial fracture and may help to identify patients who require intervention for osteoporosis.

An analysis of three fracture risk assessment tools revealed that major osteoporotic fracture risk varied by chronic kidney disease status, according to findings published in the Journal of Bone and Mineral Research.

The Endocrine Society updated its osteoporosis clinical practice guideline to include recommendations for romosozumab, noting that the monthly injection therapy is an “effective option” for postmenopausal women at high risk for fracture, according to a society press release.

A post hoc analysis of five randomized controlled trials suggests that older adults with osteoporosis assigned denosumab therapy were 20% less likely to experience a fall during follow-up compared with those assigned placebo, according to findings published in the Journal of Bone and Mineral Research.